Let’s see how many who got scaled back actually buys on market at $1.80 or below.
If history is any guide, FOMO has become FOPTM?
Printable View
Let’s see how many who got scaled back actually buys on market at $1.80 or below.
If history is any guide, FOMO has become FOPTM?
It's funny how a few days ago the thread was mostly complaining about intuitions getting a sweet deal, but now it looks like the retail investors are going to get a better price than the instos we're complaining about that instead.
When does a fluffy Siberian hamster turn into a dirty rat?
A bit of classic comedy:
Basil the hamster? https://www.youtube.com/watch?v=khoJsN3nNzM
I see a whole lot of negativity about HGH in the short-term and I don't have the same sentiment. As for the longterm it will go higher and I will look forward to the rising dividend with prudent controls on how they utilise their money. On market screener one analyst who originally thought HGH was worth $1.74 re rated it to $2.04. It is also now an Outperform.
I am not one to follow market screener without looking into the stock myself, but I am a happy holder and not selling anything yet.
https://www.marketscreener.com/quote...144/consensus/